According to Zhitong Finance App, Sinopharm Technology Co., Ltd. (08156.HK) issued an announcement. The Group expects to obtain losses attributable to company owners between HK$9 million and HK$11 million in the year ended June 30, 2026, while losses attributable to company owners were approximately HK$800,000 for the year ended June 30, 2025. The board of directors believes that the increase in losses attributable to company owners during the reporting period was mainly due to (i) the sharp year-on-year decline in revenue from the Group's supply chain service business; (ii) the increase in sales and distribution expenses during the reporting period compared to the same period in 2025, which was due to an increase in product promotion costs.

According to Zhitong Finance App, Sinopharm Technology Co., Ltd. (08156.HK) issued an announcement. The Group expects to obtain losses attributable to company owners between HK$9 million and HK$11 million in the year ended June 30, 2026, while losses attributable to company owners were approximately HK$800,000 for the year ended June 30, 2025. The board of directors believes that the increase in losses attributable to company owners during the reporting period was mainly due to (i) the sharp year-on-year decline in revenue from the Group's supply chain service business; (ii) the increase in sales and distribution expenses during the reporting period compared to the same period in 2025, which was due to an increase in product promotion costs.